180 related articles for article (PubMed ID: 7986114)
21. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
Yano M; Inoue M; Shiozaki H
Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
[TBL] [Abstract][Full Text] [Related]
22. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
23. [Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Morishima Y; Tashiro T; Yamamori H; Takagi K; Ohtsubo Y; Sugiura T; Hayashi N; Furukawa K; Itabashi T; Sano W; Toyoda Y; Nitta H; Nakajima N
Gan To Kagaku Ryoho; 1997 Jun; 24(8):965-9. PubMed ID: 9212805
[TBL] [Abstract][Full Text] [Related]
24. [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma].
Wang C; Ding T; Chang L
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):254-5. PubMed ID: 11783101
[TBL] [Abstract][Full Text] [Related]
25. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
[TBL] [Abstract][Full Text] [Related]
26. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
[TBL] [Abstract][Full Text] [Related]
27. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
Ohtsu A
Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
[TBL] [Abstract][Full Text] [Related]
28. Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline.
Malthaner R; Wong RK; Spithoff K;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):250-6. PubMed ID: 20398848
[TBL] [Abstract][Full Text] [Related]
29. [The effectiveness of chemoradiotherapy of malignant tumors using platidiam].
Monakhov BV; Fedina VA; Chichua NA; Tsoĭ AI; Borisevich NV
Vopr Onkol; 1988; 34(9):1114-8. PubMed ID: 2847430
[TBL] [Abstract][Full Text] [Related]
30. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
31. [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
Tomura K; Kogo M; Inoue T; Kaneko K; Imawari M; Yoneyama K; Kiuchi Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1807-13. PubMed ID: 18030014
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
33. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
[TBL] [Abstract][Full Text] [Related]
36. ["State of the art" of chemotherapy for lung cancer].
Fukuoka M
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2429-36. PubMed ID: 8279838
[TBL] [Abstract][Full Text] [Related]
37. Surgical adjuvant treatment of esophageal carcinoma: a Japanese Esophageal Oncology Group experience.
Iizuka T
Semin Oncol; 1994 Aug; 21(4):462-6. PubMed ID: 8042044
[TBL] [Abstract][Full Text] [Related]
38. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
39. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
Nakamura T; Ide H; Eguchi R; Hayashi K; Ota M; Narumiya K; Takasaki K; Mitsuhashi M
Gan To Kagaku Ryoho; 2003 Jun; 30(6):803-7. PubMed ID: 12852347
[TBL] [Abstract][Full Text] [Related]
40. [A case report of esophageal small cell carcinoma responding well to chemotherapy of 5-FU and cisplatin combined with radiotherapy].
Yoshikawa T; Kato H; Nikkuni K; Sasaki K; Tomidokoro T; Satoh T
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1181-4. PubMed ID: 10431586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
